Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-23,580
Closed -$1.32M 32
2016
Q4
$1.32M Hold
23,580
0.51% 39
2016
Q3
$1.4M Hold
23,580
0.37% 58
2016
Q2
$1.3M Hold
23,580
0.24% 72
2016
Q1
$1.19M Sell
23,580
-247,469
-91% -$12.1M 0.14% 78
2015
Q4
$13.7M Sell
271,049
-4,402
-2% -$222K 0.96% 35
2015
Q3
$13M Sell
275,451
-6,880
-2% -$365K 0.62% 46
2015
Q2
$15.3M Hold
282,331
0.56% 47
2015
Q1
$15.5M Hold
282,331
0.56% 47
2014
Q4
$15.3M Hold
282,331
0.69% 45
2014
Q3
$16M Hold
282,331
0.53% 53
2014
Q2
$15.6M Hold
282,331
0.49% 55
2014
Q1
$15.3M Sell
282,331
-190,317
-40% -$9.85M 0.5% 53
2013
Q4
$22.6M Buy
472,648
+209,600
+80% +$9.58M 0.71% 49
2013
Q3
$11.9M Hold
263,048
0.43% 56
2013
Q2
$11.7M Buy
+263,048
New +$11.7M 0.43% 57

Other funds holding MRK

Amici Capital's MRK Position: Q1 2017 in Review

Amici Capital sold out of Merck (MRK) in Q1 2017, closing a stake of 23,580 shares — an estimated $1.32M sold.

Amici Capital first reported a position in MRK in Q2 2013 and held it in 15 quarters. The position peaked at $22.6M in Q4 2013. 1,942 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Amici Capital reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Amici Capital sold 23,580 Merck shares in Q1 2017, an estimated $1.32M.
  • Amici Capital first reported a position in Merck in Q2 2013 and held it in 15 quarters.
  • Amici Capital's Merck position peaked at $22.6M in Q4 2013.
  • 1,942 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Amici Capital's 13F filing for Q1 2017.